英国跨性别与性别多元人群癌症危险因素患病率的横断面分析
基于英国临床实践研究数据链1988–2020年的横断面分析,纳入3474名跨女性、3591名跨男性及各约13万名顺性别男女,比较癌症危险因素患病率。跨男性肥胖(27.5%)和曾吸烟(60.2%)最高,跨女性血脂异常(15.1%)、糖尿病(5.4%)、丙肝(0.7%)、乙肝(0.4%)和HIV(0.8%)最高,多变量模型显示跨性别与性别多元人群的多种癌症危险因素患病率仍高于顺性别者。
要点
- 跨男性肥胖和曾吸烟患病率分别为27.5%和60.2%,为各组最高。
- 跨女性血脂异常、糖尿病、丙肝、乙肝和HIV患病率分别为15.1%、5.4%、0.7%、0.4%和0.8%。
- 多变量调整后,跨性别与性别多元人群的多种癌症危险因素患病率仍高于顺性别者。
核心结论
- 跨性别与性别多元(TGD)个体的多种癌症危险因素患病率高于顺性别个体。
研究设计与样本
- 横断面分析,使用英国临床实践研究数据链(CPRD)1988–2020年数据识别TGD个体。
- TGD个体按索引日期、全科诊所和索引年龄与20名顺性别男性及20名顺性别女性匹配。
- 出生指定性别根据性别肯定激素使用、手术及病历中性别特异性诊断确定。
主要发现
- 跨男性肥胖患病率27.5%、曾吸烟患病率60.2%,为各组最高。
- 跨女性血脂异常15.1%、糖尿病5.4%、丙肝0.7%、乙肝0.4%、HIV 0.8%,为各组最高。
- 多变量模型调整年龄、入组年份及适当调整肥胖后,TGD人群上述患病率估计仍高于顺性别者。
临床怎么用
- 在全科诊疗中应关注TGD个体的癌症危险因素筛查与预防,包括肥胖、吸烟、血脂异常、糖尿病及乙肝、丙肝、HIV感染。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transgender and gender diverse (TGD) individuals experience an incongruence between their assigned birth sex and gender identity. They may have a higher prevalence of health conditions associated with cancer risk than cisgender people. AIM: To examine the prevalence of several cancer risk factors among TGD individuals compared with cisgender individuals. DESIGN AND SETTING: A cross-sectional analysis was conducted using data from the UK's Clinical Practice Research Datalink to identify TGD individuals between 1988-2020, matched to 20 cisgender men and 20 cisgender women on index date (date of diagnosis with gender incongruence), practice, and index age (age at index date). Assigned birth sex was determined from gender-affirming hormone use and procedures, and sex-specific diagnoses documented in the medical record. METHOD: The prevalence of each cancer risk factor was calculated and the prevalence ratio by gender identity was estimated using log binomial or Poisson regression models adjusted for age and year at study entry, and obesity where appropriate. RESULTS: There were 3474 transfeminine (assigned male at birth) individuals, 3591 transmasculine (assigned female at birth) individuals, 131 747 cisgender men, and 131 827 cisgender women. Transmasculine people had the highest prevalence of obesity (27.5%) and 'ever smoking' (60.2%). Transfeminine people had the highest prevalence of dyslipidaemia (15.1%), diabetes (5.4%), hepatitis C infection (0.7%), hepatitis B infection (0.4%), and HIV infection (0.8%). These prevalence estimates remained elevated in the TGD populations compared with cisgender persons in the multivariable models. CONCLUSION: Multiple cancer risk factors are more prevalent among TGD individuals compared with cisgender individuals. Future research should examine how minority stress contributes to the increased prevalence of cancer risk factors in this population.
引用
- Brown J, Pfeiffer RM, Shrewsbury D, et al. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data. Br J Gen Pract. 2023. PMID: 37365010. doi:10.3399/BJGP.2023.0023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。